Gland Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
1,442.55
1,465.49
1,453.14
1,579.60
1,582.55
Other Income Qtr Cr58.4959.6651.4342.1537.39
Operating Revenues Qtr1,384.051,405.831,401.711,537.451,545.16

*All values are in Cr.

Operating Expenses Qtr
1,024.10
1,108.78
1,137.31
1,178.80
1,188.76
Operating Profit Qtr
359.96
297.06
264.40
358.65
356.39
EBIDT Qtr Cr
418.45
356.72
315.82
400.80
393.78
Depreciation Qtr
96.32
93.83
91.96
92.61
105.34
Net Profit Qtr
204.69
163.53
143.76
192.42
191.86
Basic EPS Qtr
12.42
9.93
8.73
11.68
11.65
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -